banner

ECCRT Data Transparency Conference

Beyond being required by law, data transparency in clinical trials is also an ethical and business critical aspect of drug development. Data Transparency is important to reduce avoidable burden on and/or risk to trial subjects due to the avoidance of unwarranted trial repetition, enable data-driven decisions by healthcare professionals, regulators, price selection, and pharmaceutical companies, and finally to ensure unbiased reporting of clinical trials. Throughout this Conference, we will tackle data transparency from different angles with experts from the field.

3 Key objectives for this Conference:

  1. Enable a realistic assessment of what is required, and how these requirements could be met
  2. Share information with peers as this topic is complex and dynamic and it is hard to be up-to-date on all developments
  3. Establish and facilitate contacts between different players of the industry, the academic world, regulators and service providers

 

AGENDA

12 FEB
Session 1: Regulatory Aspects & Updates
Session 2: Regulatory Aspects & Updates
Session 3: How are the rules lived
Session 4: Pro-active Approach

13 FEB
Session 5: Anonymisation
Session 6: Workshop around anonymisations
Session 7: The future of Data Transparency - Panel discussion

A detailed programme can be found here.

 

More information & registration via: http://www.eccrt.com/events/eccrt-data-transparency-conference

Event Details

Date:

Tuesday, February 12, 2019 - Wednesday, February 13, 2019

Location:

BIP
2 Rue Royale
1000 Brussels

Price:

Please find an overview of tickets here.

Organiser(s):

2019-02-12 08:00:00 2019-02-13 16:00:00 Europe/Brussels ECCRT Data Transparency Conference BIP2 Rue Royale1000 Brussels <p><a href="http://www.eccrt.com/" target="_blank">ECCRT</a></p>

More info?

For any further information about this event, please do not hesitate to get in touch with our Event Coordinator

Alternate Text

Lissa Van Hecke

Event Coordinator

| |

Interested in a regular update of the Life Sciences and biotech sector in Flanders?